WSU researchers see health effects across generations from popular weed killer

April 23, 2019

PULLMAN, Wash. - Washington State University researchers have found a variety of diseases and other health problems in the second- and third-generation offspring of rats exposed to glyphosate, the world's most popular weed killer. In the first study of its kind, the researchers saw descendants of exposed rats developing prostate, kidney and ovarian diseases, obesity and birth abnormalities.

Michael Skinner, a WSU professor of biological sciences, and his colleagues exposed pregnant rats to the herbicide between their eighth and 14th days of gestation. The dose--half the amount expected to show no adverse effect--produced no apparent ill effects on either the parents or the first generation of offspring.

But writing in the journal Scientific Reports, the researchers say they saw "dramatic increases" in several pathologies affecting the second and third generations. The second generation had "significant increases" in testis, ovary and mammary gland diseases, as well as obesity. In third-generation males, the researchers saw a 30 percent increase in prostate disease--three times that of a control population. The third generation of females had a 40 percent increase in kidney disease, or four times that of the controls.

More than one-third of the second-generation mothers had unsuccessful pregnancies, with most of those affected dying. Two out of five males and females in the third generation were obese.

Skinner and his colleagues call this phenomenon "generational toxicology" and they've seen it over the years in fungicides, pesticides, jet fuel, the plastics compound bisphenol A, the insect repellant DEET and the herbicide atrazine. At work are epigenetic changes that turn genes on and off, often because of environmental influences.

Skinner said he decided to study glyphosate "due to it being one of the most commonly used compounds worldwide."

The chemical has been the subject of numerous studies about its health effects. The Skinner study is the third in the past few months out of Washington alone. A University of Washington study published in February found the chemical increased the risk of non-Hodgkin lymphoma by as much as 41 percent. A Washington State University study published in December found state residents living close to areas subject to treatments with the herbicide are one-third more likely to die an early death from Parkinson's disease.

The chemical's generational toxicology represents a new downside that Skinner and his colleagues said should be incorporated into estimates of its risk.

"The ability of glyphosate and other environmental toxicants to impact our future generations needs to be considered," they write, "and is potentially as important as the direct exposure toxicology done today for risk assessment."
-end-
The research was supported by a grant from the John Templeton Foundation. The paper's co-authors are Undergraduate Researcher Deepika Kubsad, Research Assistant Professor Eric Nilsson, Research Assistant Stephanie King, Senior Research Associate Ingrid Sadler-Riggleman and Research Associate Daniel Beck.

Washington State University

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.